PTC Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 136.6% | 100.1% | 0.1% | 1.6% | 3.8% | 3.1% | 5.4% | 3.7% | 6.1% | 4.4% | 4.4% | 3.8% | 4.2% | 3.7% | 6.0% | 7.0% | 3.9% | 4.1% | 7.7% | 6.3% | 4.7% | 5.6% | 6.8% | 5.8% | 6.5% | 6.5% | 6.4% | 6.0% | 4.8% | 34.6% | 7.0% | 8.3% | 5.5% | 7.6% | 1.1% | 6.4% | 54.9% | 9.9% | 10.3% | 5.5% | 17.9% | |
| -36.6% | -0.1% | 99.9% | 98.4% | 96.2% | 96.9% | 94.6% | 96.3% | 93.9% | 95.6% | 95.6% | 96.2% | 95.8% | 96.3% | 94.0% | 93.0% | 96.1% | 95.9% | 92.3% | 93.7% | 95.3% | 94.4% | 93.2% | 94.2% | 93.5% | 93.5% | 93.6% | 94.0% | 95.2% | 65.4% | 93.0% | 91.7% | 94.5% | 92.4% | 98.9% | 93.6% | 45.1% | 90.1% | 89.7% | 94.5% | 82.1% | |
| 136.6% | 103.3% | 103.1% | 64.3% | 71.7% | 37.5% | 55.9% | 47.4% | 101.4% | 62.1% | 98.1% | 70.1% | 88.3% | 84.8% | 132.0% | 234.6% | 78.5% | 99.3% | 114.1% | 107.5% | 94.3% | 90.7% | 94.2% | 95.0% | 76.2% | 112.7% | 88.5% | 86.9% | 83.5% | 39.5% | 55.3% | 70.8% | 82.0% | 58.5% | 9.3% | 63.2% | 47.5% | 80.8% | 37.0% | 27.5% | 43.0% | |
| 102.9% | 289.6% | 96.1% | 60.2% | 75.1% | 109.9% | 58.8% | 48.8% | 71.6% | 121.5% | 75.7% | 57.5% | 69.0% | 144.1% | 85.3% | 71.3% | 48.8% | 49.0% | 0.1% | 59.0% | 49.9% | 45.1% | 41.4% | 39.1% | 36.9% | 59.1% | 40.5% | 18.9% | 41.1% | 26.3% | 34.9% | 37.2% | 37.3% | 39.7% | 6.9% | 47.7% | 39.8% | 58.8% | 31.6% | 22.4% | 34.5% | |
| 239.5% | 199.2% | 199.1% | 124.5% | 170.0% | 89.9% | 124.4% | 104.4% | 183.9% | 125.5% | 185.1% | 135.4% | 167.2% | 171.8% | 230.2% | 341.9% | 142.6% | 177.0% | 175.5% | 178.1% | 162.4% | 145.6% | 151.4% | 150.0% | 127.4% | 213.2% | 147.0% | 192.1% | 155.3% | 64.4% | 114.6% | 113.2% | 122.2% | 168.5% | 16.4% | 113.2% | 43.6% | 139.7% | 72.9% | 53.2% | 70.6% | |
| -139.5% | -99.2% | -99.3% | -26.1% | -73.8% | 7.0% | -29.9% | -8.1% | -90.0% | -52.3% | -129.0% | -45.3% | -84.7% | -75.5% | -136.2% | -248.9% | -46.6% | -81.1% | -83.2% | -84.4% | -67.1% | -51.3% | -58.2% | -55.8% | -33.8% | -119.7% | -53.4% | -98.0% | -60.1% | 1.0% | -21.6% | -21.5% | -27.7% | -76.2% | 82.5% | -19.5% | 1.4% | -49.6% | 16.8% | 41.3% | 11.5% | |
| 9.3% | 8.4% | 8.4% | 6.3% | 8.2% | 4.4% | 5.9% | 4.2% | 5.8% | 3.8% | 4.3% | 2.4% | 3.7% | 5.7% | 8.3% | 7.1% | 17.8% | 20.4% | 16.2% | 19.3% | 15.7% | 13.6% | 15.8% | 13.3% | 9.6% | 14.6% | 12.4% | 13.8% | 14.3% | 14.4% | 19.4% | 23.3% | 21.1% | 19.3% | 2.9% | 17.0% | 15.4% | 33.5% | 18.0% | 13.4% | 18.4% | |
| -152.2% | -104.9% | -108.8% | -36.1% | -80.2% | 2.7% | -34.0% | -13.3% | -94.4% | -57.1% | -133.5% | -48.0% | -84.5% | -69.5% | -164.8% | -241.0% | -40.0% | -51.9% | -108.7% | -101.0% | -96.3% | -83.9% | -82.0% | -89.8% | -58.6% | -113.3% | -61.3% | -111.1% | -84.7% | -51.1% | -40.3% | -45.9% | -49.8% | -44.4% | 79.1% | -39.7% | -10.9% | -84.5% | -0.9% | 27.1% | -6.6% | |
| 0.8% | 1.4% | 0.6% | 0.3% | 0.5% | 1.1% | 0.4% | 0.6% | 0.7% | -1.2% | 1.1% | 0.9% | -0.5% | 11.0% | 0.3% | 0.1% | 18.8% | 10.6% | 0.4% | 0.4% | 0.0% | 2.8% | 3.3% | 2.0% | -8.2% | -11.2% | 1.8% | -18.1% | -17.1% | -0.4% | 3.3% | 7.2% | 4.4% | -13.5% | 5.4% | -3.5% | -18.5% | -2.5% | 0.1% | 3.9% | -2.8% | |
| -153.0% | -106.4% | -109.5% | -36.4% | -80.6% | 1.6% | -34.4% | -13.8% | -95.1% | -56.0% | -134.6% | -48.9% | -84.0% | -80.5% | -165.1% | -241.1% | -58.9% | -62.6% | -109.1% | -101.5% | -96.3% | -86.7% | -85.2% | -91.9% | -50.3% | -102.1% | -63.1% | -93.0% | -67.6% | -50.7% | -43.6% | -53.1% | -54.2% | -30.9% | 73.7% | -36.3% | 7.5% | -82.0% | -1.0% | 23.2% | -3.8% | |
| -136.0% | -93.3% | -97.0% | -24.3% | -49.2% | 14.6% | -19.1% | 0.9% | -75.4% | -21.8% | -117.9% | -36.5% | -69.4% | -53.0% | -143.0% | -220.3% | -12.4% | -21.1% | -80.9% | -68.9% | -68.5% | -58.9% | -48.5% | -58.9% | -31.6% | -75.5% | -29.4% | -73.5% | -37.6% | -10.4% | 5.5% | -18.9% | -25.4% | -22.0% | 82.6% | -18.5% | 9.8% | -43.1% | 22.7% | 44.9% | 17.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.